´ëÇѾÏÇÐȸ Á¦2ȸ AACR(American Association for Cancer Research)-KCA(Korean Cancer Association) Joint Conference on Precision Medicine in Solid Tumors ¹× Á¦24Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö 1 : 2021-11-11±³À°ÀÏÀÚ : 2021-11-11
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È»ó °ÀÇ) ¹× ¼¿ï·Ôµ¥È£ÅÚ 2Ãþ Å©¸®½ºÅ»º¼·ë 2°³·ë
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) Á¦2ȸ AACR(American Association for Cancer Research)-KCA(Korean Cancer Association) Joint Conference on Precision Medicine in Solid Tumors ¹× Á¦24Â÷ ´ëÇѾÏÇÐȸ Ãß°è½ÉÆ÷Áö¾ö 1 ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486
À̸ÞÀÏ :
cancer2@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 9 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 300,000¿ø
ºñ°í 1. »çÀüµî·Ï: 1) ȸ¿ø 10¸¸¿ø, 2) ºñȸ¿ø 15¸¸¿ø, 3) ¾÷ü¹×¿¬±¸¼Ò 20¸¸¿ø, 4) Trainee ¹«·á2. ÀϹݵî·Ï: 1) ȸ¿ø 20¸¸¿ø, 2) ºñȸ¿ø 25¸¸¿ø, 3) ¾÷ü¹×¿¬±¸¼Ò 30¸¸¿ø, 4) Trainee 3¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-11 Room A 08:10~08:40 Progress in targeting KRAS(kirsten rat sarcoma viral oncogene homolog) directly Frank McCormick(UCSF Helen Diller Family Comprehensive Cancer Center)
ÈÞ½Ä 11-11 08:40~09:00 ÈÞ½Ä ()
±³À°½Ã°£ 11-11 Room A 09:00~09:25 Immune approaches to cancer therapy: Building on lessons checkpoint blockade Jedd D. Wolchok(Memorial Sloan Kettering Cancer Center)
±³À°½Ã°£ 11-11 Room A 09:25~09:50 Next generation immunotherapy beyond anti-PD-1 (programmed cell death-1) and CTLA4 (cytotoxic T-lymphocyte-associated protein 4) ¾È¸íÁÖ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-11 Room A 09:50~10:15 Academic clinical trials of CAR T (chimeric antigen receptor-T) cell therapy for cancer Marcela V. Maus(Harvard Medical School)
±³À°½Ã°£ 11-11 Room A 10:15~10:40 To be announced ÀÓ¼®¾Æ(¼¿ïÀÇ´ë)
ÈÞ½Ä 11-11 10:40~11:00 ÈÞ½Ä ()
±³À°½Ã°£ 11-11 Room A 11:00~11:25 Proteomic characterization of the RAS (renin angiotensin system) secretome Peter K. Jackson(Stanford University)
±³À°½Ã°£ 11-11 Room A 11:25~11:50 Mobilization of LINE-1 retrotransposons in colorectal epithelium ÁÖ¿µ¼®(KAIST)
±³À°½Ã°£ 11-11 Room A 11:50~12:15 Systematic elucidation and pharmacological targeting of non-oncogene dependencies in single cells Andrea Califano(Columbia University)
±³À°½Ã°£ 11-11 Room A 12:15~12:40 Gastric cancer proteogenomics Ȳ´ëÈñ(¼¿ï´ë)
½Ä»ç 11-11 12:40~13:10 ½Ä»ç ()
±³À°½Ã°£ 11-11 Room A 13:10~13:40 Transforming the treatment paradigm in GC(gastric cancer)/ GEJ(gastroesophageal junction)/ EAC(esophageal adenocarcinoma) 1L: Nivolumab + Chemotherapy ¹Ú¼÷·Ã(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-11 Room A 13:40~14:10 Innovative treatment of aRCC(advanced renal cell carcinoma) 1L with superior long-term efficacy and tolerability: Nivolumab + Ipilimumab ¹ÚÀαÙ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 11-11 Room B 13:10~13:30 Pembrolizumab+Lenvatinib: The optimal combination treatment for advanced solid tumors ±è¹Îȯ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-11 Room B 13:30~13:50 Enable comprehensive genomic profiling liquid biopsy ÀåÀÚÇö(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 11-11 Room B 13:50~14:10 Larotrectinib – A new ive TRK(tropomyosin receptor kinase) inhibitor for NTRK(neurotrophic tyrosine receptor kinase) fusion-positive cancer patients ÀÌ´ëÈ£(¿ï»êÀÇ´ë)
ÈÞ½Ä 11-11 14:10~14:30 ÈÞ½Ä ()
±³À°½Ã°£ 11-11 Room A 14:30~15:30 Proffered Papers Session ¹ÌÁ¤()
ÈÞ½Ä 11-11 15:30~15:50 ÈÞ½Ä ()
±³À°½Ã°£ 11-11 Room A 15:50~16:15 Breast cancer ÀÌÁ¤¾ð(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-11 Room A 16:15~16:40 Current issues in neoadjuvant therapy of lung cancer ³ª±ÇÁß(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 11-11 Room A 16:40~17:05 Surgery after neoadjuvant therapy for locally advanced or borderline resectable pancreatic cancer ¼Û±âº´(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-11 Room B 15:50~16:15 Medical image analysis using deep learning ¹Ú»óÇö(DGIST)
±³À°½Ã°£ 11-11 Room B 16:15~16:40 AI(artificial intelligence) application in cancer imaging ¼Áعü(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-11 Room B 16:40~17:05 AI(artificial intelligence) application in pathology ±è¼®ÈÖ(¾ÆÁÖÀÇ´ë)